Partner – Organisation and Leadership — Care-Delivery Network

The mandate

An advisory partnership is planning succession for a Partner who has guided numerous US healthcare integrations. Current clients are acquiring care-delivery networks whose value depends on retaining local clinical leadership while introducing common operating authority. The replacement Partner – Organisation and Leadership must bring an approach grounded in patient pathways, executive behaviour and measurable decisions rather than generic culture programmes.

Approximately 875 employees and material partners form the addressable advisory, clinical, people, analytics and implementation perimeter. The Partner reports to the Global Managing Partner and regional partner council, with responsibility for client origination, organisation engagements, risk, economics and talent.

Organisation design will start with work. Teams must understand how referrals, care decisions, staffing, capacity and escalation move across the acquired and acquiring entities. Reporting lines should follow the accountabilities needed to deliver these pathways. A neat chart that leaves competing clinical and operating authority unresolved is not a finished design.

Clinical governance requires special care. Medical leadership may sit within employed groups, affiliated practices and site committees. The Partner will help clients distinguish professional authority, management accountability and board oversight. Integration cannot simply subordinate all clinicians to a corporate executive, nor can historic autonomy exempt leaders from enterprise standards.

Leadership selection needs evidence and legitimacy. Future roles will be defined before incumbents are assessed, using operating scenarios, track record and behaviour. The Partner will prevent acquisition politics from becoming hidden criteria. Where leaders are not selected, communication and transition should preserve dignity, clinical continuity and necessary knowledge.

Decision rights will be tested through real cases. Who can close a service temporarily, redirect patients, approve a premium roster or act on a practitioner concern? The team will facilitate decisions under simulated and live conditions, documenting escalation and fixing ambiguity. A responsibility matrix is useful only if leaders use it when stakes rise.

Culture diagnosis will focus on reinforced behaviour. Incentives, meeting routines, information flow and leadership consequences often matter more than stated values. The Partner will examine where people remain silent, which legacy wins are celebrated and whether teams share adverse information. Interventions should alter these conditions, not merely increase workshop attendance.

Retention decisions require precision. The loudest executive is not necessarily the carrier of scarce integration knowledge. The Partner will identify clinicians, schedulers, referral coordinators and technical leaders whose departure could interrupt care, then connect retention to transfer milestones. Blanket bonuses dilute credibility and may entrench roles the future organisation does not need.

Workforce change must comply with law and with the client's responsibility to patients. Consultation, selection, redeployment and severance plans will include operational sequencing. Savings cannot be realised on paper while managers quietly backfill removed work through contractors or overtime. The Partner will connect organisation benefits to workforce and service evidence.

Leadership team formation will use live enterprise priorities. Executives need to make contested choices about site autonomy, capacity and investment together. The Partner will observe how they use evidence, surface disagreement and own decisions. Coaching will have defined goals; persistent avoidance or political obstruction should be reported candidly to the sponsor.

The advisory practice will measure integration outcomes beyond engagement completion. Measures include decision speed, critical-role retention, leadership effectiveness, layer reduction, service continuity and benefit realisation. Data will be contextualised, and the Partner will revisit clients after implementation to test whether the model endured.

Client independence and confidentiality are material. Organisation projects expose succession views, practitioner concerns and workforce plans. Access will be limited and sensitive judgements separated from broad project materials. Serving competing providers or investors requires conflict analysis beyond formal legal checks.

The retiring Partner's accounts must be transferred well. The successor will join client conversations early, share credit with emerging colleagues and create a practice that survives another leadership change. Winning work personally while delivery and relationships remain dependent on one individual would repeat the issue being solved.

What you will own

• Healthcare organisation and leadership proposition.
• Work-led organisation design and decision rights.
• Clinical, management and board-accountability integration.
• Executive selection, team effectiveness and succession.
• Culture, retention and workforce-change architecture.
• Client outcomes, engagement economics and confidentiality.
• Account transition and emerging-partner development.
• US market reputation and practice contribution.

The first 12 months

In the first 60 days, review inherited clients, live integrations and partner dependencies. Join critical succession conversations and establish a healthcare-specific organisation diagnostic.

By month six, lead two major integration designs through selection and live decision testing, while transferring priority accounts to shared leadership. Introduce post-implementation outcome reviews.

At twelve months, generate USD 50 million of quality-reviewed revenue at target contribution, achieve 90% retention of identified care-critical talent through required transitions and verify that client executives independently execute key decision rights. At least 75% of inherited accounts should have two credible partner relationships, with no material confidentiality or selection-process breach.

What the council will assess

• Organisation choices derived from patient and operating work.
• Clinical authority distinguished from management hierarchy.
• Selection criteria set before incumbent evaluation.
• Decision rights functioning under real pressure.
• Retention focused on scarce care capability.
• Client trust distributed across the practice.

The person

You bring 22–28 years in organisation, leadership, healthcare consulting or executive people roles. Your record includes post-acquisition care-delivery integration, senior selection and organisation implementation across multiple US sites. You have advised boards through contested leadership choices and remained accountable for operational consequences.

Candidates should be able to show measurable change after a design was implemented, not only a completed blueprint. US employment and healthcare governance knowledge are important. The hybrid Boston appointment entails extensive client presence and travel.

Compensation and terms

Base compensation is USD 360,000–480,000 plus annual incentive and long-term participation linked to client outcomes, practice contribution, leadership transition, quality delivery and partner development. This planned replacement is a permanent advisory appointment under a hybrid Boston model, reporting to the Global Managing Partner and regional partner council.

Confidentiality

The partnership, clients, acquired entities, executives, practitioners, workforce plans and selection judgements are confidential. Further detail follows conflict review and signed confidentiality. Candidates must not approach healthcare boards, advisers or possible incumbents to identify the mandate.